Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.

Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr, Regain Study Group

Open source

DOI: 10.1002/mus.26447
Published: 2019 Jul
Container: Muscle & nerve
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/mus.26447,
  title = {Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.},
  author = {Muppidi S and Utsugisawa K and Benatar M and Murai H and Barohn RJ and Illa I and Jacob S and Vissing J and Burns TM and Kissel JT and Nowak RJ and Andersen H and Casasnovas C and de Bleecker JL and Vu TH and Mantegazza R and O'Brien FL and Wang JJ and Fujita KP and Howard JF Jr and Regain Study Group},
  year = {2019},
  journal = {Muscle \& nerve},
  doi = {10.1002/mus.26447},
  url = {https://doi.org/10.1002/mus.26447}
}

RIS

TY  - JOUR
TI  - Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
AU  - Muppidi S
AU  - Utsugisawa K
AU  - Benatar M
AU  - Murai H
AU  - Barohn RJ
AU  - Illa I
AU  - Jacob S
AU  - Vissing J
AU  - Burns TM
AU  - Kissel JT
AU  - Nowak RJ
AU  - Andersen H
AU  - Casasnovas C
AU  - de Bleecker JL
AU  - Vu TH
AU  - Mantegazza R
AU  - O'Brien FL
AU  - Wang JJ
AU  - Fujita KP
AU  - Howard JF Jr
AU  - Regain Study Group
PY  - 2019
JO  - Muscle & nerve
DO  - 10.1002/mus.26447
UR  - https://doi.org/10.1002/mus.26447
ER  -

APA

S, M., K, U., M, B., H, M., RJ, B., I, I., S, J., J, V., TM, B., JT, K., RJ, N., H, A., C, C., JL, D. B., TH, V., R, M., FL, O., JJ, W., KP, F., Jr, H. J., & Group, R. S. (2019). Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.. Muscle & nerve. https://doi.org/10.1002/mus.26447

Source records

pubmed · retrieved 2026-09-27T10:23:31.704Z